{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:29:21Z","timestamp":1790278161460,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:00:00Z","timestamp":1674086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:00:00Z","timestamp":1674086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The UCSD Huntington\u2019s Disease Society of America Center of Excellence"},{"name":"The UCSD Shiley-Marcos Alzheimer\u2019s Disease Research Center","award":["NIH P50 AG005131"],"award-info":[{"award-number":["NIH P50 AG005131"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS111655"],"award-info":[{"award-number":["NS111655"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Measuring Huntingtin (HTT) protein in peripheral cells represents an essential step in biomarker discovery for Huntington\u2019s Disease (HD), however to date, investigations into the salivary expression of HTT has been lacking. In the current study, we quantified total HTT (tHTT) and mutant HTT (mHTT) protein in matched blood and saliva samples using single molecule counting (SMC) immunoassays: 2B7-D7F7 (tHTT) and 2B7-MW1 (mHTT). Matched samples, and clinical data, were collected from 95 subjects: n\u2009=\u200919 manifest HD, n\u2009=\u200934 premanifest HD (PM), and n\u2009=\u200942 normal controls (NC). Total HTT and mHTT levels were not correlated in blood and saliva. Plasma tHTT was significantly associated with age, and participant sex; whereas salivary mHTT was significantly correlated with age, CAG repeat length and CAP score. Plasma and salivary tHTT did not differ across cohorts. Salivary and plasma mHTT were significantly increased in PM compared to NC; salivary mHTT was also significantly increased in HD compared to NC. Only salivary tHTT and mHTT were significantly correlated with clinical measures. Salivary HTT is uniquely associated with clinical measures of HD and offers significant promise as a relevant, non-invasive HD biomarker. Its use could be immediately implemented into both translational and clinical research applications.<\/jats:p>","DOI":"10.1038\/s41598-023-28019-y","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T06:06:06Z","timestamp":1674108366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Salivary Huntingtin protein is uniquely associated with clinical features of Huntington\u2019s disease"],"prefix":"10.1038","volume":"13","author":[{"given":"Georgia M.","family":"Parkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Corey-Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chase","family":"Snell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haileigh","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Laurenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Daldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Bresciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,19]]},"reference":[{"issue":"10","key":"28019_CR1","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1073\/pnas.0308679101","volume":"101","author":"NS Wexler","year":"2004","unstructured":"Wexler, N. S. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset. Proc. Natl. Acad. Sci. USA. 101(10), 3498\u20133503 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"issue":"3","key":"28019_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1469-1809.2006.00335.x","volume":"71","author":"JM Andresen","year":"2007","unstructured":"Andresen, J. M. et al. The relationship between cag repeat length and age of onset differs for Huntington\u2019s disease patients with juvenile onset or adult onset. Ann. Hum. Genet. 71(3), 295\u2013301 (2007).","journal-title":"Ann. Hum. Genet."},{"issue":"4","key":"28019_CR3","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/ng0893-398","volume":"4","author":"SE Andrew","year":"1993","unstructured":"Andrew, S. E. et al. The relationship between trinucleotide (cag) repeat length and clinical features of Huntington\u2019s disease. Nat. Genet. 4(4), 398\u2013403 (1993).","journal-title":"Nat. Genet."},{"issue":"1","key":"28019_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2011.12.013","volume":"238","author":"M Arrasate","year":"2012","unstructured":"Arrasate, M. & Finkbeiner, S. Protein aggregates in Huntington\u2019s disease. Exp. Neurol. 238(1), 1\u201311 (2012).","journal-title":"Exp. Neurol."},{"issue":"12","key":"28019_CR5","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/nrn1806","volume":"6","author":"E Cattaneo","year":"2005","unstructured":"Cattaneo, E., Zuccato, C. & Tartari, M. Normal huntingtin function: An alternative approach to Huntington\u2019s disease. Nat. Rev. Neurosci. 6(12), 919\u2013930 (2005).","journal-title":"Nat. Rev. Neurosci."},{"issue":"458","key":"28019_CR6","doi-asserted-by":"publisher","first-page":"eaat7108","DOI":"10.1126\/scitranslmed.aat7108","volume":"10","author":"LM Byrne","year":"2018","unstructured":"Byrne, L. M. et al. Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington\u2019s disease. Sci. Transl. Med. 10(458), eaat7108 (2018).","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"28019_CR7","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1172\/JCI80743","volume":"125","author":"EJ Wild","year":"2015","unstructured":"Wild, E. J. et al. Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington\u2019s disease patients. J. Clin. Investig. 125(5), 1979\u20131986 (2015).","journal-title":"J. Clin. Investig."},{"issue":"574","key":"28019_CR8","doi-asserted-by":"publisher","first-page":"eabc2888","DOI":"10.1126\/scitranslmed.abc2888","volume":"12","author":"FB Rodrigues","year":"2020","unstructured":"Rodrigues, F. B. et al. Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington\u2019s disease. Sci. Transl. Med. 12(574), eabc2888 (2020).","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"28019_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-25095-3","volume":"8","author":"J Corey-Bloom","year":"2018","unstructured":"Corey-Bloom, J. et al. Salivary levels of total huntingtin are elevated in Huntington\u2019s disease patients. Sci. Rep. 8(1), 1\u20139 (2018).","journal-title":"Sci. Rep."},{"issue":"2","key":"28019_CR10","first-page":"136","volume":"11","author":"K Kieburtz","year":"2001","unstructured":"Kieburtz, K. et al. Unified Huntington\u2019s disease rating scale: Reliability and consistency. Neurology 11(2), 136\u2013142 (2001).","journal-title":"Neurology"},{"issue":"8","key":"28019_CR11","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/jcph.1598","volume":"60","author":"W Sun","year":"2020","unstructured":"Sun, W. et al. Huntington\u2019s disease progression: A population modeling approach to characterization using clinical rating scales. J. Clin. Pharmacol. 60(8), 1051\u20131060 (2020).","journal-title":"J. Clin. Pharmacol."},{"issue":"3","key":"28019_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein, M. F., Folstein, S. E. & McHugh, P. R. \u201cMini-mental state\u201d: A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12(3), 189\u2013198 (1975).","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"28019_CR13","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine, Z. S. et al. The montreal cognitive assessment, moca: A brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 53(4), 695\u2013699 (2005).","journal-title":"J. Am. Geriatr. Soc."},{"key":"28019_CR14","volume-title":"A Compendium of Neuropsychological Tests","author":"A Smith","year":"1982","unstructured":"Smith, A. Symbol digit modalities test. In A Compendium of Neuropsychological Tests 2nd edn (eds Spreen, O. & Strauss, E.) (Western Psychological Services, 1982).","edition":"2"},{"issue":"4","key":"28019_CR15","first-page":"219","volume":"14","author":"D Craufurd","year":"2001","unstructured":"Craufurd, D., Thompson, J. C. & Snowden, J. S. Behavioral changes in Huntington disease. Cogn. Behav. Neurol. 14(4), 219\u2013226 (2001).","journal-title":"Cogn. Behav. Neurol."},{"issue":"6","key":"28019_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond, A. S. & Snaith, R. P. The hospital anxiety and depression scale. Acta Psychiatr. Scand. 67(6), 361\u2013370 (1983).","journal-title":"Acta Psychiatr. Scand."},{"issue":"24","key":"28019_CR17","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1212\/WNL.0000000000004743","volume":"89","author":"SA Schobel","year":"2017","unstructured":"Schobel, S. A. et al. Motor, cognitive, and functional declines contribute to a single progressive factor in early hd. Neurology 89(24), 2495\u20132502 (2017).","journal-title":"Neurology"},{"issue":"2","key":"28019_CR18","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ajmg.b.30992","volume":"153","author":"DR Langbehn","year":"2010","unstructured":"Langbehn, D. R., Hayden, M. R., Paulsen, J. S., PREDICT\u2010HD Investigators. Cag-repeat length and the age of onset in Huntington disease (HD): A review and validation study of statistical approaches. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153(2), 397\u2013408 (2010).","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"2","key":"28019_CR19","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/mds.26838","volume":"32","author":"JD Long","year":"2017","unstructured":"Long, J. D. et al. Validation of a prognostic index for Huntington\u2019s disease. Mov. Disord. 32(2), 256\u2013263 (2017).","journal-title":"Mov. Disord."},{"key":"28019_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-35784-9","volume-title":"Salivary Bioscience: Foundations of Interdisciplinary Saliva Research and Applications","author":"DA Granger","year":"2020","unstructured":"Granger, D. A. & Taylor, M. K. Salivary Bioscience: Foundations of Interdisciplinary Saliva Research and Applications (Springer Nature, 2020)."},{"key":"28019_CR21","doi-asserted-by":"crossref","unstructured":"Fodale, V. et al. Quantifying huntingtin protein in human cerebrospinal fluid using a novel polyglutamine length-independent assay. J. Huntingtons Dis. 1\u201315 (2022) (in Press).","DOI":"10.3233\/JHD-220527"},{"issue":"4","key":"28019_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3233\/JHD-170269","volume":"6","author":"V Fodale","year":"2017","unstructured":"Fodale, V. et al. Validation of ultrasensitive mutant huntingtin detection in human cerebrospinal fluid by single molecule counting immunoassay. J. Huntingtons Dis. 6(4), 349\u2013361 (2017).","journal-title":"J. Huntingtons Dis."},{"issue":"10","key":"28019_CR23","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.3390\/ijms23105598","volume":"23","author":"H Ananbeh","year":"2022","unstructured":"Ananbeh, H. et al. Huntingtin co-isolates with small extracellular vesicles from blood plasma of tghd and ki-hd pig models of Huntington\u2019s disease and human blood plasma. Int. J. Mol. Sci. 23(10), 5598 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"28019_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S0169-328X(99)00097-2","volume":"69","author":"F Wilkinson","year":"1999","unstructured":"Wilkinson, F. et al. Localization of rabbit huntingtin using a new panel of monoclonal antibodies. Mol. Brain Res. 69(1), 10\u201320 (1999).","journal-title":"Mol. Brain Res."},{"issue":"3\u20134","key":"28019_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0361-9230(01)00599-8","volume":"56","author":"J Ko","year":"2001","unstructured":"Ko, J., Ou, S. & Patterson, P. H. New anti-huntingtin monoclonal antibodies: Implications for huntingtin conformation and its binding proteins. Brain Res. Bull. 56(3\u20134), 319\u2013329 (2001).","journal-title":"Brain Res. Bull."},{"issue":"S37","key":"28019_CR26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/jcb.10073","volume":"84","author":"EE Schadt","year":"2001","unstructured":"Schadt, E. E., Li, C., Ellis, B. & Wong, W. H. Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data. J. Cell Biochem. 84(S37), 120\u2013125 (2001).","journal-title":"J. Cell Biochem."},{"issue":"1","key":"28019_CR27","first-page":"1","volume":"19","author":"T V\u00e4likangas","year":"2018","unstructured":"V\u00e4likangas, T., Suomi, T. & Elo, L. L. A systematic evaluation of normalization methods in quantitative label-free proteomics. Brief Bioinform. 19(1), 1\u201311 (2018).","journal-title":"Brief Bioinform."},{"issue":"1","key":"28019_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2091-14-34","volume":"14","author":"L Massai","year":"2013","unstructured":"Massai, L. et al. Development of an elisa assay for the quantification of soluble huntingtin in human blood cells. BMC Biochem. 14(1), 1\u20139 (2013).","journal-title":"BMC Biochem."},{"issue":"5","key":"28019_CR29","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1093\/brain\/116.5.1201","volume":"116","author":"E Storey","year":"1993","unstructured":"Storey, E. & Beal, M. Neurochemical substrates of rigidity and chorea in Huntington\u2019s disease. Brain 116(5), 1201\u20131222 (1993).","journal-title":"Brain"},{"key":"28019_CR30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.parkreldis.2021.04.017","volume":"87","author":"GM Parkin","year":"2021","unstructured":"Parkin, G. M., Corey-Bloom, J., Snell, C., Castleton, J. & Thomas, E. A. Plasma neurofilament light in Huntington\u2019s disease: A marker for disease onset, but not symptom progression. Parkinsonism Relat. Disord. 87, 32\u201338 (2021).","journal-title":"Parkinsonism Relat. Disord."},{"issue":"12","key":"28019_CR31","doi-asserted-by":"publisher","first-page":"8808","DOI":"10.1074\/jbc.M109.075028","volume":"285","author":"C Landles","year":"2010","unstructured":"Landles, C. et al. Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease. J. Biol. Chem. 285(12), 8808\u20138823 (2010).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"28019_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12014-007-9000-x","volume":"3","author":"F Chevalier","year":"2007","unstructured":"Chevalier, F. et al. Proteomic studies of saliva: A proposal for a standardized handling of clinical samples. Clin. Proteomics. 3(1), 13\u201321 (2007).","journal-title":"Clin. Proteomics."},{"issue":"4","key":"28019_CR33","doi-asserted-by":"publisher","first-page":"e0266812","DOI":"10.1371\/journal.pone.0266812","volume":"17","author":"DF Fischer","year":"2022","unstructured":"Fischer, D. F. et al. Development of mab-based polyglutamine-dependent and polyglutamine length-independent huntingtin quantification assays with cross-site validation. PLoS ONE 17(4), e0266812 (2022).","journal-title":"PLoS ONE"},{"issue":"1","key":"28019_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-78790-5","volume":"10","author":"V Fodale","year":"2020","unstructured":"Fodale, V. et al. Analysis of mutant and total huntingtin expression in Huntington\u2019s disease murine models. Sci. Rep. 10(1), 1\u201313 (2020).","journal-title":"Sci. Rep."},{"issue":"2","key":"28019_CR35","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s11095-005-9045-3","volume":"23","author":"JW Lee","year":"2006","unstructured":"Lee, J. W. et al. Fit-for-purpose method development and validation for successful biomarker measurement. Pharm. Res. 23(2), 312\u2013328 (2006).","journal-title":"Pharm. Res."},{"issue":"1","key":"28019_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/prd.12116","volume":"70","author":"GB Proctor","year":"2016","unstructured":"Proctor, G. B. The physiology of salivary secretion. Periodontol. 70(1), 11\u201325 (2016).","journal-title":"Periodontol."},{"key":"28019_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-3-319-19285-7_7","volume-title":"The Neuropathology of Huntington\u2019s Disease: Classical Findings, Recent Developments and Correlation to Functional Neuroanatomy","author":"U R\u00fcb","year":"2015","unstructured":"R\u00fcb, U., Vonsattel, J. P. G., Heinsen, H. & Korf, H.-W. Widespread brainstem neurodegeneration in Huntington\u2019s disease (hd). In The Neuropathology of Huntington\u2019s Disease: Classical Findings, Recent Developments and Correlation to Functional Neuroanatomy Vol. 217 83\u201390 (Springer, 2015)."},{"issue":"12","key":"28019_CR38","doi-asserted-by":"publisher","first-page":"e0189891","DOI":"10.1371\/journal.pone.0189891","volume":"12","author":"DJ Hensman Moss","year":"2017","unstructured":"Hensman Moss, D. J. et al. Quantification of huntingtin protein species in Huntington\u2019s disease patient leukocytes using optimised electrochemiluminescence immunoassays. PLoS ONE 12(12), e0189891 (2017).","journal-title":"PLoS ONE"},{"issue":"10","key":"28019_CR39","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1172\/JCI64565","volume":"122","author":"A Weiss","year":"2012","unstructured":"Weiss, A. et al. Mutant huntingtin fragmentation in immune cells tracks Huntington\u2019s disease progression. J. Clin. Investig 122(10), 3731\u20133736 (2012).","journal-title":"J. Clin. Investig"},{"issue":"15","key":"28019_CR40","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1016\/j.jmb.2015.05.023","volume":"427","author":"GE Owens","year":"2015","unstructured":"Owens, G. E., New, D. M., West, A. P. Jr. & Bjorkman, P. J. Anti-polyq antibodies recognize a short polyq stretch in both normal and mutant huntingtin exon 1. J. Mol. Biol. 427(15), 2507\u20132519 (2015).","journal-title":"J. Mol. Biol."},{"issue":"20","key":"28019_CR41","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1093\/hmg\/ddt273","volume":"22","author":"FA Klein","year":"2013","unstructured":"Klein, F. A. et al. Linear and extended: A common polyglutamine conformation recognized by the three antibodies mw1, 1c2 and 3b5h10. Hum. Mol. Genet. 22(20), 4215\u20134223 (2013).","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"28019_CR42","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nsmb1234","volume":"14","author":"P Li","year":"2007","unstructured":"Li, P. et al. The structure of a polyq\u2013anti-polyq complex reveals binding according to a linear lattice model. Nat. Struct. Mol. Biol. 14(5), 381\u2013387 (2007).","journal-title":"Nat. Struct. Mol. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28019-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28019-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28019-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T06:15:12Z","timestamp":1674108912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28019-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,19]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["28019"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-28019-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1970399\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,19]]},"assertion":[{"value":"17 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1034"}}